OMND — Optimind Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Optimind Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

	2021 December 31st	2023 February 28th	2024 February 29th	2025 February 28th	2026 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.001	0.552	0.029	0.084	0.099
Net Total Accounts Receivable
Net Total Receivables	—	0.116	0.159	0.066	0.043
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.022	0.668	0.188	0.15	0.143
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.095	0	—	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	0.022	1.35	0.238	0.2	0.143
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.188	0.625	0.367	0.275	0.33
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	0.188	0.715	0.367	0.275	0.33
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.166	0.64	-0.129	-0.075	-0.187
Total Liabilities & Shareholders' Equity	0.022	1.35	0.238	0.2	0.143
Total Common Shares Outstanding